image-comparison grip-lines arrow-top-right zip arrow-right video minus arrow-back text shop twitter file home quick-order arrow-left youtube search arrow-down check all filter site_references image Slice 1 zoom 🎬 icons / _ icon size / _ download-queue Created with Sketch. chevron-down arrow-right picture pdf podcast exe plus hotline close xxx-1 burger clipboard linked-in ppt Artboard 🎬 icons / _ icon size / _ download-queue_add Created with Sketch. Layer 1 Created by potrace 1.15, written by Peter Selinger 2001-2017 My Account press_releases Created with Sketch. PRESS ds-instruments ds-preventive ds-implants ds-endodontics Cart presentation Created with Sketch. DS-Preventive-Icon-Grey video Created with Sketch. other Created with Sketch. text_piece Created with Sketch. promotion Created with Sketch. Spare Parts ds-imaging-systems case_study Created with Sketch. ds-treatment-centers broschure Created with Sketch. ds-prosthetics ds-restorative video Created with Sketch. flyer Created with Sketch. whitepaper Created with Sketch. article Created with Sketch. image Created with Sketch. Service ds-cad-cam Artboard Quick Order Dentist Chair study Created with Sketch. ds-orthodontics ds-implants ds-endodontics ds-cerec digital-scan grinder ds-diagnosis step_1 analyse ds-abutment-placement more-quality initiative scan more-quality ds-polishing digital ds-irrigation ds-treatment-centers Test treatment ds-restorative ds-implant-planning realistic construct book ds-planning-impression mirror anwender ds-preventive planning-2 ds-obturation ds-cad-cam 04 ds-implant-placement ds-retention-protection ds-anesthetics restauration form ds-inlab oven CORP-icon-grey-screen-tooth-cavity-pulpa robot plan place ds-orthodontics PDF-Formular_ganzneu PDF overlay ds-bone-regeneration ds-treatment-preparation vorher_nachher ds-maging-systems wifi omnicam PDF-Formular_neu_vonGünther treatment consulting planning comparison ds-set-up ds-prosthetics support step_3 ds-tooth-preparation ds-treatments ds-scaling step_2 ds-instruments software quote-english quote-french quote-text-german Created with Sketch. upload Created with Sketch. version Created with Sketch. globe
  • Implant Dentistry

Datum Dental, Ltd. and Dentsply Sirona Implants Enter Distribution Agreement in the USA

Growing Momentum for the Ossix Brand

Datum Dental, Ltd, leading provider of OSSIX® brand innovative solutions for bone and tissue regeneration for dentistry, announces expansion of its global distribution network. In the USA, Dentsply Sirona Implants is now promoting the full OSSIX® line (OSSIX Plus, OSSIX Volumax, and OSSIX Bone).

The distribution collaboration was formally announced at the recent Academy of Osseointegration (AO) Annual Meeting in Los Angeles. Powered by the company’s patented GLYMATRIX® technology, OSSIX products are covered by over 110 scientific publications and extensive clinical experience with thousands of clinicians. Superior clinical results were discussed on podium at the AO and featured in presentations such as a new independent, comparative study of soft and hard tissue parameters by researchers Hong, Chen, Kim and Machtei at Harvard School of Dental Medicine and Rambam Healthcare Campus.

“We welcome our new partners and thank our existing network for ongoing cooperation--we are encouraged by continued momentum,” said Daniel Levitats, VP of Sales and Marketing, “To enable enhanced support for all our partners and growth of the OSSIX brand, we have also expanded our Sales & Marketing team. There is great traction for our OSSIX brand, including the newest member of the product family, OSSIX Bone, launched in 3Q2017 in the USA, now available in Israel and Chile, with CE Mark in process for Europe. There is high adoption in strategic regions for our GLYMATRIX-based scaffold, OSSIX Volumax, and continued growth for our legacy product, the OSSIX Plus ossifying collagen membrane. We are transforming and simplifying the work of clinicians--enabling specialists and general practitioners to benefit from our expanding portfolio. ”

“Offering the OSSIX products alongside our SYMBIOS portfolio propels Dentsply Sirona Implants into the future of regenerative dentistry,” said Jennifer DiPietro, head of Regenerative Solutions for Dentsply Sirona Implants. “We provide comprehensive offerings to customers that re-create and preserve hard and soft tissues.  We are excited to deliver the innovative solutions and proven technologies of the OSSIX line. With this collaboration with Datum Dental Ltd, we have the opportunity to bring established quality and meaningful innovation together to our customers”

Around the globe, Datum Dental's Partner Network also continues to extend its reach to new territories such as Argentina, Belgium, Colombia, Greece, Scandinavia, Singapore, and Vietnam, with more new partnerships in the pipeline.

About Datum Dental

Datum Dental Ltd., a subsidiary of Datum Biotech, provides innovative dental regeneration products, aiming to support and enhance the future of implantology and oral care. The company markets its products for dental professionals through its extensive global network of over 20 partners worldwide. The company’s uses its patented GLYMATRIX® core technology, a sugar cross-linking collagen biomaterial, for guided bone regeneration (GBR) and guided tissue regeneration (GTR). Powered by GLYMATRIX®, the OSSIX® product family has enabled clinicians in hundreds of thousands of procedures in over 30 countries to safely provide predictable, long-term results to their patients. Datum Dental’s R&D pipeline continues to develop new, safe and transformational solutions – that simplify procedures and overcome major deficiencies in existing biomaterial‐based regenerative products.

About Dentsply Sirona Implants

Dentsply Sirona Implants offers comprehensive solutions for all phases of implant therapy, including Ankylos, Astra Tech Implant System and Xive implant lines, digital technologies, such as Atlantis patient-specific CAD/CAM solutions and Simplant guided surgery, Symbios regenerative solutions, and professional development programs. Dentsply Sirona Implants creates value for dental professionals and allows for predictable and lasting implant treatment outcomes, resulting in enhanced quality of life for patients.



Ellen Fischl Bodner
Director of Marketing
Datum Dental


Jennifer DiPietro, DVM

Manager, Global Biomaterials

Dentsply Sirona Implants

Download Material

OSSIX product boxes high-res.jpg
(798 kB)

Whitepaper added to Download Queue

Already in collection



This information and any attachment thereto contains forward-looking information about Dentsply Sirona, Inc.'s financial results, guidance and estimates, business prospects, and products and services that involve substantial risks and uncertainties or other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You can identify these statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions which identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and involve known and unknown risks and uncertainties, and other factors. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental product and services, pricing, future sales volume of the Company's products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company in its Annual Report on Form 10-K and in its reports on Forms 10-Q and 8-K filed with the U.S. Securities and Exchange Commission. The Company assumes no obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.